Vivici, a Dutch ingredients startup, launched Vivitein BLG in the U.S. market.

The flagship ingredient under its Vivitein protein platform, Vivitein BLG is available now, enabling B2B customers to launch "disruptive and differentiated products to consumers in the U.S. market," the company said.

Vivitein BLG is a dairy protein (beta-lactoglobulin) which is produced through precision fermentation, with no animals involved in the production process. The ingredient is self-affirmed GRAS (Generally Recognised as Safe) in the U.S., the company noted.

"As the role of protein in an active lifestyle continues to rise, American consumers demand a higher quantity and quality of protein in their diets," said Stephan van Sint Fiet, CEO of Vivici. "Vivitein BLG brings a new standard of protein to the US active nutrition market – one that enables companies to deliver on consumer demand in a way that no other protein has before."

Precision fermentation – the method used by Vivici to create dairy protein - combines the process of traditional fermentation with the latest advances in biotechnology, producing proteins without the need for animals. The technology promises to sustainably meet the protein needs of the world's growing population, without compromising on price, taste, or nutritional quality.

"Our journey to-date has seen us rigorously demonstrate the game-changing credentials of Vivitein BLG from both a sustainability and commercial perspective," said van Sint Fiet. "When we say that Vivitein BLG is a new standard of protein, it's so much more than marketing."